Advisor Group Holdings, Inc. Intra Cellular Therapies, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $39.8 Billion
  • Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,614 shares of ITCI stock, worth $332,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,614
Previous 1,654 58.04%
Holding current value
$332,004
Previous $120,000 81.67%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
BUY
$71.19 - $91.57 $68,342 - $87,907
960 Added 58.04%
2,614 $218,000
Q3 2024

Nov 13, 2024
SELL
$67.99 - $80.84 $19,581 - $23,281
-288 Reduced 14.83%
1,654 $120,000
Q2 2024

Aug 13, 2024
BUY
$64.76 - $79.84 $57,765 - $71,217
892 Added 84.95%
1,942 $133,000
Q1 2024

May 10, 2024
SELL
$64.37 - $75.65 $782,224 - $919,298
-12,152 Reduced 92.05%
1,050 $72,000
Q4 2023

Feb 12, 2024
BUY
$46.37 - $73.65 $377,683 - $599,879
8,145 Added 161.06%
13,202 $945,000
Q3 2023

Nov 13, 2023
BUY
$52.09 - $64.1 $54,017 - $66,471
1,037 Added 25.8%
5,057 $263,000
Q2 2023

Aug 10, 2023
BUY
$54.67 - $66.44 $25,202 - $30,628
461 Added 12.95%
4,020 $254,000
Q1 2023

May 12, 2023
BUY
$43.8 - $56.99 $19,491 - $25,360
445 Added 14.29%
3,559 $192,000
Q4 2022

Feb 10, 2023
SELL
$44.07 - $54.45 $8,549 - $10,563
-194 Reduced 5.86%
3,114 $164,000
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $581,744 - $817,303
-13,624 Reduced 80.46%
3,308 $154,000
Q2 2022

Aug 10, 2022
SELL
$43.0 - $65.64 $329,079 - $502,342
-7,653 Reduced 31.13%
16,932 $966,000
Q1 2022

May 04, 2022
BUY
$38.74 - $62.09 $915,232 - $1.47 Million
23,625 Added 2460.94%
24,585 $1.5 Million
Q3 2021

Nov 05, 2021
SELL
$28.72 - $42.49 $4,193 - $6,203
-146 Reduced 13.2%
960 $36,000
Q2 2021

Aug 02, 2021
BUY
$29.3 - $44.5 $11,573 - $17,577
395 Added 55.56%
1,106 $45,000
Q1 2021

May 13, 2021
SELL
$30.8 - $39.51 $770 - $987
-25 Reduced 3.4%
711 $24,000
Q4 2020

Feb 10, 2021
SELL
$23.34 - $32.22 $2,730 - $3,769
-117 Reduced 13.72%
736 $23,000
Q3 2020

Nov 12, 2020
SELL
$17.61 - $31.86 $26,591 - $48,108
-1,510 Reduced 63.9%
853 $22,000
Q2 2020

Aug 14, 2020
BUY
$14.35 - $26.64 $3,056 - $5,674
213 Added 9.91%
2,363 $60,000
Q1 2020

May 18, 2020
BUY
$12.31 - $33.12 $26,466 - $71,208
2,150 New
2,150 $33,000

Others Institutions Holding ITCI

# of Institutions
387
Shares Held
85.9M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email